Phase I Trial for Pharmacokinetic Characteristics of Factive 200mg Intravenous Formulation (Gemifloxacin 200mg) With Factive 320mg Tablet Formulation (Gemifloxacin 320mg)
Clinical trial NCT01879007 · COMPLETED
Trial details
- NCT number
- NCT01879007
- Sponsor
- LG Life Sciences
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2006-01-01
- Primary completion
- 2006-03-01
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.